Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Colorectal Neoplasms × XELOX × Clear all

Phase

Phase 2 14 Phase 3 5 Phase 2/3 2 Phase 1 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Colorectal Neoplasms 1

Interventions

Capecitabine 11 Fluorouracil 9 Oxaliplatin 7 Bevacizumab 7 Leucovorin 5 Irinotecan 4 HMPL-013 4 Folfox protocol 4 Cetuximab 4 ferric carboxymaltose 3 regorafenib 2 gadolinium ethoxybenzyl DTPA 2 gadobenic acid 2 Triamcinolone 2 Standard of Care 2 Radiofrequency Ablation 2 Pirinitramide 2 Morphine 2 Esomeprazole 2 Analgesia, Epidural 2 sodium phosphate 1 raltitrexed 1 polyethylene glycol 3350 1 iron isomaltoside 1000 1 gadoteridol 1 gadoterate meglumine 1 gadodiamide 1 gadobutrol 1 fish oil triglycerides 1 ferrous sulfate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06115174 2023-11-02

CRC - PTX

Tanta University

Phase 4 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡